|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Baguley BC: Multiple drug resistance
mechanisms in cancer. Mol Biotechnol. 46:308–316. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gonzalez-Angulo AM, Morales-Vasquez F and
Hortobagyi GN: Overview of resistance to systemic therapy in
patients with breast cancer. Adv Exp Med Biol. 608:1–22. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Moulder S: Intrinsic resistance to
chemotherapy in breast cancer. Womens Health (Lond). 6:821–830.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Taylor S, Spugnini EP, Assaraf YG,
Azzarito T, Rauch C and Fais S: Microenvironment acidity as a major
determinant of tumor chemoresistance: Proton pump inhibitors (PPIs)
as a novel therapeutic approach. Drug Resist Updat. 23:69–78. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Baldini N, Scotlandi K, Barbanti-Bròdano
G, Manara MC, Maurici D, Bacci G, Bertoni F, Picci P, Sottili S,
Campanacci M, et al: Expression of P-glycoprotein in high-grade
osteosarcomas in relation to clinical outcome. N Engl J Med.
333:1380–1385. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Serra M, Scotlandi K, Manara MC, Maurici
D, Benini S, Sarti M, Campanacci M and Baldini N: Analysis of
P-glycoprotein expression in osteosarcoma. Eur J Cancer.
31A:1998–2002. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ferrari S, Bertoni F, Zanella L, Setola E,
Bacchini P, Alberghini M, Versari M and Bacci G: Evaluation of
P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and
metachronous lung metastases in patients with high-grade
osteosarcoma. Cancer. 100:1936–1942. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao Y, Zhang CL, Zeng BF, Wu XS, Gao TT
and Oda Y: Enhanced chemosensitivity of drug-resistant osteosarcoma
cells by lentivirus-mediated Bcl-2 silencing. Biochem Biophys Res
Commun. 390:642–647. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song B, Wang Y, Xi Y, Kudo K, Bruheim S,
Botchkina GI, Gavin E, Wan Y, Formentini A, Kornmann M, et al:
Mechanism of chemoresistance mediated by miR-140 in human
osteosarcoma and colon cancer cells. Oncogene. 28:4065–4074. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kaplan RN, Riba RD, Zacharoulis S, Bramley
AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, et
al: VEGFR1-positive haematopoietic bone marrow progenitors initiate
the pre-metastatic niche. Nature. 438:820–827. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kato Y, Ozawa S, Miyamoto C, Maehata Y,
Suzuki A, Maeda T and Baba Y: Acidic extracellular microenvironment
and cancer. Cancer Cell Int. 13:892013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
McIntyre A and Harris AL: The role of ph
regulation in cancer progression. Recent Results Cancer Res.
207:93–134. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Trédan O, Galmarini CM, Patel K and
Tannock IF: Drug resistance and the solid tumor microenvironment. J
Natl Cancer Inst. 99:1441–1454. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Damaghi M, Wojtkowiak JW and Gillies RJ:
pH sensing and regulation in cancer. Front Physiol. 4:3702013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Avnet S, Lemma S, Cortini M, Pellegrini P,
Perut F, Zini N, Kusuzaki K, Chano T, Grisendi G, Dominici M, et
al: Altered pH gradient at the plasma membrane of osteosarcoma
cells is a key mechanism of drug resistance. Oncotarget.
7:63408–63423. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Luciani F, Spada M, De Milito A, Molinari
A, Rivoltini L, Montinaro A, Marra M, Lugini L, Logozzi M, Lozupone
F, et al: Effect of proton pump inhibitor pretreatment on
resistance of solid tumors to cytotoxic drugs. J Natl Cancer Inst.
96:1702–1713. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pérez-Sayáns M, Somoza-Martin JM,
Barros-Angueira F, Diz PG, Rey JM and Garcia-Garcia A: Multidrug
resistance in oral squamous cell carcinoma: The role of vacuolar
ATPases. Cancer Lett. 295:135–143. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nabeshima K, Iwasaki H, Koga K, Hojo H,
Suzumiya J and Kikuchi M: Emmprin (basigin/CD147): Matrix
metalloproteinase modulator and multifunctional cell recognition
molecule that plays a critical role in cancer progression. Pathol
Int. 56:359–367. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang JM, Xu Z, Wu H, Zhu H, Wu X and Hait
WN: Overexpression of extracellular matrix metalloproteinase
inducer in multidrug resistant cancer cells. Mol Cancer Res.
1:420–427. 2003.PubMed/NCBI
|
|
21
|
Marieb EA, Zoltan-Jones A, Li R, Misra S,
Ghatak S, Cao J, Zucker S and Toole BP: Emmprin promotes
anchorage-independent growth in human mammary carcinoma cells by
stimulating hyaluronan production. Cancer Res. 64:1229–1232. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou S, Liao L, Chen C, Zeng W, Liu S, Su
J, Zhao S, Chen M, Kuang Y, Chen X and Li J: CD147 mediates
chemoresistance in breast cancer via ABCG2 by affecting its
cellular localization and dimerization. Cancer Lett. 337:285–292.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qin Z, Dai L, Bratoeva M, Slomiany MG,
Toole BP and Parsons C: Cooperative roles for emmprin and LYVE-1 in
the regulation of chemoresistance for primary effusion lymphoma.
Leukemia. 25:1598–1609. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Slomiany MG, Grass GD, Robertson AD, Yang
XY, Maria BL, Beeson C and Toole BP: Hyaluronan, CD44, and emmprin
regulate lactate efflux and membrane localization of
monocarboxylate transporters in human breast carcinoma cells.
Cancer Res. 69:1293–1301. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gallagher SM, Castorino JJ, Wang D and
Philp NJ: Monocarboxylate transporter 4 regulates maturation and
trafficking of CD147 to the plasma membrane in the metastatic
breast cancer cell line MDA-MB-231. Cancer Res. 67:4182–4189. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao S, Chen C, Liu S, Zeng W, Su J, Wu L,
Luo Z, Zhou S, Li Q, Zhang J, et al: CD147 promotes MTX resistance
by immune cells through up-regulating ABCG2 expression and
function. J Dermatol Sci. 70:182–189. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen X, Su J, Chang J, Kanekura T, Li J,
Kuang YH, Peng S, Yang F, Lu H and Zhang JL: Inhibition of CD147
gene expression via RNA interference reduces tumor cell
proliferation, activation, adhesion, and migration activity in the
human Jurkat T-lymphoma cell line. Cancer Invest. 26:689–697. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. 25:402–408. 2001.
|
|
29
|
Lebeau A, Kriegsmann M, Burandt E and Sinn
HP: Invasive breast cancer: The current WHO classification.
Pathologe. 35:7–17. 2014.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
McCarty KS Jr, Miller LS, Cox EB, Konrath
J and McCarty KS Sr: Estrogen receptor analyses. Correlation of
biochemical and immunohistochemical methods using monoclonal
antireceptor antibodies. Arch Pathol Lab Med. 109:716–721.
1985.PubMed/NCBI
|
|
32
|
Chen M, Huang SL, Zhang XQ, Zhang B, Zhu
H, Yang VW and Zou XP: Reversal effects of pantoprazole on
multidrug resistance in human gastric adenocarcinoma cells by
down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling
pathway in vitro and in vivo. J Cell Biochem. 113:2474–2487. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Franck P, Petitipain N, Cherlet M,
Dardennes M, Maachi F, Schutz B, Poisson L and Nabet P: Measurement
of intracellular pH in cultured cells by flow cytometry with
BCECF-AM. J Biotechnol. 46:187–195. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liao L, Song M, Li X, Tang L, Zhang T,
Zhang L, Pan Y, Chouchane L and Ma X: E3 ubiquitin ligase UBR5
drives the growth and metastasis of triple negative breast cancer.
Cancer Res. 77:2090–2101. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vichai V and Kirtikara K: Sulforhodamine B
colorimetric assay for cytotoxicity screening. Nat Protoc.
1:1112–1116. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Quail DF and Joyce JA: Microenvironmental
regulation of tumor progression and metastasis. Nat Med.
19:1423–1437. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cotter K, Capecci J, Sennoune S, Huss M,
Maier M, Martinez-Zaguilan R and Forgac M: Activity of plasma
membrane V-ATPases is critical for the invasion of MDA-MB231 breast
cancer cells. J Biol Chem. 290:3680–3692. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hrabeta J, Groh T, Khalil MA, Poljakova J,
Adam V, Kizek R, Uhlik J, Doktorova H, Cerna T, Frei E, et al:
Vacuolar-ATPase-mediated intracellular sequestration of ellipticine
contributes to drug resistance in neuroblastoma cells. Int J Oncol.
47:971–980. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
García-García A, Pérez-Sayáns García M,
Rodríguez MJ, Antúnez-López J, Barros-Angueira F, Somoza-Martín M,
Gándara-Rey JM and Aguirre-Urízar JM: Immunohistochemical
localization of C1 subunit of V-ATPase (ATPase C1) in oral squamous
cell cancer and normal oral mucosa. Biotech Histochem. 87:133–139.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Muramatsu T: Basigin (CD147), a
multifunctional transmembrane glycoprotein with various binding
partners. J Biochem. 159:481–490. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kasinrerk W, Tokrasinwit N and Phunpae P:
CD147 monoclonal antibodies induce homotypic cell aggregation of
monocytic cell line U937 via LFA-1/ICAM-1 pathway. Immunology.
96:184–192. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Curtin KD, Meinertzhagen IA and Wyman RJ:
Basigin (EMMPRIN/CD147) interacts with integrin to affect cellular
architecture. J Cell Sci. 118:2649–2660. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Takahashi M, Suzuki S and Ishikawa K:
Cyclophilin A-EMMPRIN interaction induces invasion of head and neck
squamous cell carcinoma. Oncol Rep. 27:198–203. 2012.PubMed/NCBI
|
|
44
|
Grass GD, Dai L, Qin Z, Parsons C and
Toole BP: CD147: Regulator of hyaluronan signaling in invasiveness
and chemoresistance. Adv Cancer Res. 123:351–373. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li QQ, Wang WJ, Xu JD, Cao XX, Chen Q,
Yang JM and Xu ZD: Involvement of CD147 in regulation of multidrug
resistance to P-gp substrate drugs and in vitro invasion in breast
cancer cells. Cancer Sci. 98:1064–1069. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Jamali S, Klier M, Ames S, Barros LF,
McKenna R, Deitmer JW and Becker HM: Hypoxia-induced carbonic
anhydrase IX facilitates lactate flux in human breast cancer cells
by non-catalytic function. Sci Rep. 5:136052015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Toole BP and Slomiany MG: Hyaluronan, CD44
and Emmprin: Partners in cancer cell chemoresistance. Drug Resist
Updat. 11:110–121. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li X, Yu X, Dai D, Song X and Xu W: The
altered glucose metabolism in tumor and a tumor acidic
microenvironment associated with extracellular matrix
metalloproteinase inducer and monocarboxylate transporters.
Oncotarget. 7:23141–23155. 2016.PubMed/NCBI
|
|
49
|
Kendrick AA, Schafer J, Dzieciatkowska M,
Nemkov T, D'Alessandro A, Neelakantan D, Ford HL, Pearson CG,
Weekes CD, Hansen KC and Eisenmesser EZ: CD147: A small molecule
transporter ancillary protein at the crossroad of multiple
hallmarks of cancer and metabolic reprogramming. Oncotarget.
8:6742–6762. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ellsworth RE, Decewicz DJ, Shriver CD and
Ellsworth DL: Breast cancer in the personal genomics era. Curr
Genomics. 11:146–161. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ferrari S, Perut F, Fagioli F, Del Prever
Brach A, Meazza C, Parafioriti A, Picci P, Gambarotti M, Avnet S,
Baldini N and Fais S: Proton pump inhibitor chemosensitization in
human osteosarcoma: From the bench to the patients' bed. J Transl
Med. 11:2682013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Spugnini EP, Buglioni S, Carocci F,
Francesco M, Vincenzi B, Fanciulli M and Fais S: High dose
lansoprazole combined with metronomic chemotherapy: A phase I/II
study in companion animals with spontaneously occurring tumors. J
Transl Med. 12:2252014. View Article : Google Scholar : PubMed/NCBI
|
